Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection Reactivation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04405011
What this trial is testing

NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHC

Who this might be right for
HBV/HCV Co-infection
National Taiwan University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00711035
What this trial is testing

Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)

Who this might be right for
Adenovirus InfectionEBV Infection
Baylor College of Medicine 50
Not applicableUnknownNCT00489151
What this trial is testing

Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

Who this might be right for
Hepatitis B
Hospital Authority, Hong Kong 70
Not applicableStudy completedNCT00091884
What this trial is testing

Efficacy of Elevated CD4 Counts on CMV Retinitis

Who this might be right for
Acquired Immunodeficiency SyndromeCytomegalovirus Retinitis
National Eye Institute (NEI) 15
Not applicableLooking for participantsNCT07609576
What this trial is testing

Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.

Who this might be right for
Lymphoma NeoplasmsMyeloma MultipleSevere Infection+3 more
Infanta Leonor University Hospital 350
Large-scale testing (Phase 3)Study completedNCT00378976
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

Who this might be right for
HIV InfectionHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Not applicableUnknownNCT03210090
What this trial is testing

Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients

Who this might be right for
Cytomegalovirus InfectionHSCT
Maimónides Biomedical Research Institute of Córdoba 100
Not applicableUnknownNCT06441669
What this trial is testing

Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT

Who this might be right for
Cytomegalovirus Infection Reactivation
Anhui Provincial Hospital 60
Not applicableLooking for participantsNCT04030676
What this trial is testing

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

Who this might be right for
Cytomegalovirus Infections
Centre Hospitalier Universitaire de Saint Etienne 196
Not applicableActive Not RecruitingNCT07536048
What this trial is testing

A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years

Who this might be right for
Epstein-Barr Virus (EBV)Healthy Volunteers
Sanofi Pasteur, a Sanofi Company 100
Early research (Phase 1)UnknownNCT03576014
What this trial is testing

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

Who this might be right for
Cytomegalovirus InfectionsPreventation of Cytomegalovirus ReactivationBK Virus Infection+1 more
SL VAXiGEN 18
Early research (Phase 1)Study completedNCT03035370
What this trial is testing

Viaskin Pertussis Vaccine Trial

Who this might be right for
Whooping Cough
DBV Technologies 102
Not applicableLooking for participantsNCT06916195
What this trial is testing

Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus InfectionHematopoietic Stem Cells Transplantation
MSD Italia S.r.l. 230
Not applicableStudy completedNCT06219616
What this trial is testing

Prediction of BK Virus Reactivation in Kidney Transplant Recipient

Who this might be right for
Kidney Transplant InfectionBK Virus InfectionBK Virus Nephropathy
King Chulalongkorn Memorial Hospital 80
Not applicableStudy completedNCT05419206
What this trial is testing

The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients

Who this might be right for
COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality
Ramazan Gozukucuk 167
Not applicableUnknownNCT05331417
What this trial is testing

Bronchoscopic Score for Prediction of Herpes Simplex-virus Type 1 (HSV-1) Reactivation

Who this might be right for
TracheobronchitisHerpes Simplex Infection
University Hospital Muenster 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03594981
What this trial is testing

Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis

Who this might be right for
Viral Infection
Catherine Bollard 2
Not applicableNo Longer AvailableNCT01945619
What this trial is testing

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)

Who this might be right for
EBV InfectionCMV InfectionAdenoviral Infection
Baylor College of Medicine
Not applicableStudy completedNCT00006314
What this trial is testing

Cytomegalovirus Spread and Reactivation in Blood Cells

Who this might be right for
Blood DiseaseCytomegalovirus Infections
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT03382834
What this trial is testing

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 31
Next Page